載入...
Predictive biomarkers for dasatinib treatment in melanoma
Dasatinib has anti-proliferative and anti-invasive effects in melanoma cell lines. However clinical trials have shown modest activity for dasatinib in metastatic melanoma. Although dasatinib targets SRC kinase, neither expression nor phosphorylation of SRC appears to predict response to dasatinib. I...
Na minha lista:
| 發表在: | Oncoscience |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278284/ https://ncbi.nlm.nih.gov/pubmed/25594008 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|